Developing Therapies For Autism And Making Scientists More Translational With Dr. Mark Tepper
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on May 30, 2024 11:16 ()
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 358725113 series 3401918
In this episode, Scott Wagers chats with Dr. Mark Tepper, CEO of EuMentis Therapeutics and a season innovator in life science and healthcare. The discussion ranges from the difficulties of developing therapies for autism to making basic scientists more translational. Mark opens up about his personal philosophy of getting through the many challenges of medical research and entrepreneurship. He also shares insights on guiding medical teams on performing in a more productive and collaborative way, leading to creative outputs that could stand the test of time.
12 episodes